Oncology Follow-Up and Surveillance
Structured post-treatment surveillance programme using clinical review, imaging, and tumour markers to detect cancer recurrence at the earliest treatable stage and manage long-term treatment effects.
Overview
Overview
Oncology Follow-Up and Surveillance is the structured post-treatment monitoring programme designed to detect cancer recurrence at the earliest treatable stage, manage the long-term and late effects of cancer treatment, and support the patient's physical and psychological recovery after completing primary cancer therapy. Surveillance schedules are individualised to the specific cancer type, stage, treatment received, and individual recurrence risk profile. Regular tumour marker measurement, clinical examination, and imaging at defined intervals form the core of the surveillance programme. Survivorship care also addresses lifestyle modifications proven to reduce the risk of cancer recurrence and second malignancies.
Types of Oncology Follow-Up and Surveillance
- Clinical review and examination — regular outpatient appointments to assess for symptoms and signs of recurrence and late treatment toxicity
- Tumour marker surveillance — serial measurement of cancer-specific blood markers (CEA, CA125, PSA, AFP, thyroglobulin) to detect biochemical recurrence
- Cross-sectional imaging surveillance — CT, MRI, or PET-CT scanning at defined intervals based on cancer type, stage, and recurrence risk
- Disease-specific surveillance procedures — mammography, colonoscopy, endoscopy, or skin examination depending on the primary cancer history
- Survivorship assessment — specialist management of late treatment effects including neuropathy, lymphoedema, cardiac toxicity, and bone density loss
Risk Factors of Oncology Follow-Up and Surveillance
- Completed primary cancer treatment with no current evidence of disease but significant residual recurrence risk
- High-risk pathological features (lymph node involvement, high grade, lymphovascular invasion) predicting elevated recurrence probability
- Rising tumour marker levels during surveillance indicating possible biochemical recurrence before structural recurrence is detectable on imaging
- Long-term treatment toxicity from chemotherapy, radiotherapy, or surgery requiring ongoing specialist monitoring and management
- Genetic predisposition syndrome (BRCA, Lynch syndrome, Li-Fraumeni) requiring intensified surveillance for second primary cancers
- Psychosocial impact of cancer diagnosis and treatment requiring survivorship support to facilitate return to normal life
Symptoms of Oncology Follow-Up and Surveillance
- New unexplained pain at the primary tumour site or in a new location suggesting local or metastatic recurrence
- Unexplained weight loss, fatigue, or reduced performance status suggesting systemic cancer recurrence
- New respiratory symptoms including breathlessness or persistent cough suggesting pulmonary recurrence or metastases
- Abdominal symptoms including pain, distension, or change in bowel habit suggesting intra-abdominal disease recurrence
- Neurological symptoms including headache, cognitive changes, or focal weakness suggesting brain metastases
- Swelling or palpable lymph node enlargement at a regional nodal site suggesting lymph node recurrence
- Skin or wound changes at the site of previous surgery suggesting local cutaneous recurrence
- Fatigue, cognitive impairment, and functional decline related to long-term effects of chemotherapy or radiotherapy
Key Benefits
Discover the advantages of choosing our oncology follow-up and surveillance services.
Early detection of recurrence at asymptomatic stage provides the greatest treatment options
Late effect management prevents progressive morbidity from untreated treatment toxicities
Tumour marker surveillance detects biochemical recurrence before radiological evidence
Structured survivorship planning reduces the anxiety of life after cancer treatment
Lifestyle optimisation after cancer treatment reduces recurrence risk and improves overall health
Clinical Features
The technology, techniques and clinical approach behind our oncology follow-up and surveillance.
Tumour marker trend graph maintained and rising markers trigger investigation before clinical recurrence
Late effect systematic assessment at every follow-up -- not only when the patient reports symptoms
ECOG performance status documented at every appointment tracking functional trajectory
New imaging findings discussed at MDT before any management change
Personalised survivorship care plan provided and updated at each follow-up appointment
Preparation Instructions
Keep all scheduled follow-up appointments even when you feel well -- many recurrences are detected before symptoms develop. Blood tests are usually taken 24 to 48 hours before each review. Report any new symptoms between appointments to your oncology nurse or GP -- do not wait for the next scheduled appointment if you have concerning new symptoms.
The Procedure
Step-by-step guide to what you can expect during your oncology follow-up and surveillance procedure.
Interval History and Symptom Review
The interval history systematically screens for symptoms of recurrence and late treatment effects. All symptoms are assessed and investigated appropriately. ECOG performance status is documented at every appointment.
Physical Examination
A focused clinical examination includes the primary tumour site regional lymph nodes abdominal examination and relevant system examination based on the specific cancer type and treatment history.
Tumour Marker and Blood Test Review
Tumour markers relevant to the specific cancer are measured and plotted on a trend graph. A persistently rising or suddenly elevated tumour marker triggers investigation with cross-sectional imaging before structural recurrence is clinically detectable.
Surveillance Imaging Review
CT MRI or specialist imaging is reviewed by the oncology radiologist. New findings suspicious for recurrence are discussed at MDT before any management change is implemented.
Late Effect Assessment and Management
Long-term treatment effects -- peripheral neuropathy lymphoedema cognitive effects cardiac toxicity and bone density loss -- are systematically assessed and managed at every follow-up appointment.
Survivorship Care Planning and Lifestyle Advice
A personalised survivorship care plan documenting cancer history treatment summary surveillance schedule and late effect monitoring is provided. Evidence-based lifestyle advice reducing recurrence risk is reinforced at every appointment.
What to Expect
Your oncologist or specialist nurse reviews blood results, discusses any symptoms, and examines you. Imaging results are reviewed and explained. A clear plan for the next surveillance interval is agreed. A cancer survivorship assessment addresses long-term treatment effects, psychological wellbeing, return to activity, and lifestyle recommendations.
Recovery
Maintain healthy lifestyle practices -- healthy weight, regular physical activity, minimal alcohol, no smoking, and a Mediterranean diet pattern. Contact the oncology team promptly for any new lumps, unexplained weight loss, persistent fatigue, pain, or other concerning symptoms between surveillance appointments.
Frequently Asked Questions
Common questions about oncology follow-up and surveillance.
Related Services
Explore other services in our Oncology department.
Chemotherapy Administration
Radiation Therapy
Cancer Staging and Tumour Marker Assessment
Ready to Get Started?
Schedule your consultation today and take the first step towards better health.